Hologic Asks To Pursue Makena Claims Against K-V Pharma

Law360, New York (September 6, 2012, 4:23 PM EDT) -- K-V Pharmaceutical Co. creditor Hologic Inc. asked a New York bankruptcy judge Wednesday to lift the automatic stay so it could pursue its rights with respect to its first lien on K-V's biggest asset, preterm-birth drug Makena, saying the drug's value is declining.

Hologic, a secured creditor, submitted the motion for relief from the stay to allow it to exercise its rights and remedies under an asset purchase agreement and license agreement as to its interests in the Makena assets and related property, saying it's receiving...
To view the full article, register now.